NCT00079911View on ClinicalTrials.gov

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

PHASE4TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 12, 2004

Primary Completion Date

October 15, 2004

Study Completion Date

October 15, 2004

Conditions
Herpes Genitalis
Interventions
DRUG

valacyclovir hydrochloride

valacyclovir hydrochloride

Trial Locations (5)

2010

GSK Investigational Site, Darlinghurst

32701

GSK Investigational Site, Altamonte Springs

60657

GSK Investigational Site, Chicago

02115

GSK Investigational Site, Boston

Unknown

GSK Investigational Site, Kowloon Bay

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00079911 - A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons | Biotech Hunter | Biotech Hunter